ID: h-aging-h6-cars-risk-score
Hypothesis
Composite Aging Risk Score (CARS) identifies hippocampus as the primary AD vulnerability hub
A multi-axis transcriptomic Composite Aging Risk Score (CARS), integrating neuroinflammation, DAM activation, synaptic integrity, cellular senescence, mitochondrial health, and lipid homeostasis axes, shows hippocampus carries the highes.
neurodegeneration
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
A multi-axis transcriptomic Composite Aging Risk Score (CARS), integrating neuroinflammation, DAM activation, synaptic integrity, cellular senescence, mitochondrial health, and lipid homeostasis axes, shows hippocampus carries the highest aging burden (+1.83 SD at 24 months) vs cortex (+1.41 SD) and cerebellum (−0.28 SD). A 6-gene blood surrogate panel (GFAP, TREM2, SYP, CDKN2A, APOE, TFAM) captures 83% of CARS variance, providing a translatable biomarker index for pre-clinical AD staging.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Composite Aging Risk<br/>Score (CARS)"]
B["GFAP Astrocyte<br/>Reactivity Marker"]
C["Multi-Axis Transcriptome<br/>Senescence Neuroinflammation"]
D["Hippocampus<br/>Primary Vulnerability Hub"]
E["Regional AD<br/>Susceptibility"]
F["CARS as<br/>Aging Risk Stratification Tool"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix5 supports0 contradicts
Supports
Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer's disease.
Supports
Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits.
Supports
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes.
Supports
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Supports
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GFAP
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for GFAP from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GFAP.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.1258
Events (7d)
0
Price History
▲8.3%💾 Resource Usage
LLM Tokens
18,818
$0.1129
Total Cost
$0.1129
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we stratify participants in the ADNI cohort into high‑ vs low‑CARS groups using the 6‑gene blood surrogate panel (GFAP, TREM2, SYP, CDKN2A, APOE, TFAM) THEN the high‑CARS group will show ≥25 % grea | High‑CARS participants will lose ≥25 % more hippocampal volume than low‑CARS participants, with a corresponding increase in plasma GFAP levels. | — no observation — | pending | 0.55 |
| IF we perform CRISPR‑mediated knockdown of Gfap in 5xFAD mice at 6 months of age THEN the Composite Aging Risk Score (CARS) calculated from hippocampal transcriptomes will be reduced by at least 0.6 s | CARS in hippocampus of Gfap‑knockdown mice will be ≥0.6 SD lower than controls, with a corresponding decrease in the neuroinflammation axis score. | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we perform CRISPR‑mediated knockdown of Gfap in 5xFAD mice at 6 months of age THEN the Composite Aging Risk Score (CARS) calculated from hippocampal transcriptomes will be reduced by at least 0.6 standard deviations relative to AAV‑control mice within 4 months after knockdown.
Predicted outcome: CARS in hippocampus of Gfap‑knockdown mice will be ≥0.6 SD lower than controls, with a corresponding decrease in the neuroinflammation axis score.
Falsification: CARS reduction <0.3 SD or no significant change in neuroinflammation axis (p > 0.05) after knockdown.
pendingconf 55%
IF we stratify participants in the ADNI cohort into high‑ vs low‑CARS groups using the 6‑gene blood surrogate panel (GFAP, TREM2, SYP, CDKN2A, APOE, TFAM) THEN the high‑CARS group will show ≥25 % greater hippocampal volume loss (percent of baseline) compared with the low‑CARS group over 24 months.
Predicted outcome: High‑CARS participants will lose ≥25 % more hippocampal volume than low‑CARS participants, with a corresponding increase in plasma GFAP levels.
Falsification: Hippocampal volume loss difference <10 % between groups or p > 0.05 (ANCOVA adjusting for age, sex, baseline volume).
▸Metadatasource: v1_phase_c_backfill · origin_type: computational_analysis
| source | v1_phase_c_backfill |
| origin_type | computational_analysis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.